Literature DB >> 7000284

Advances in the management of adult acute myelogenous leukaemia.

J A Whittaker.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 7000284      PMCID: PMC1714324          DOI: 10.1136/bmj.281.6246.960

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  49 in total

1.  A randomized clinical trial of daunorubicin and a combination of prednisone, vincristine, 6-mercaptopurine, and methotrexate in adult acute nonlymphocytic leukemia.

Authors:  P H Wiernik; A A Serpick
Journal:  Cancer Res       Date:  1972-10       Impact factor: 12.701

2.  Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.

Authors:  J W Yates; H J Wallace; R R Ellison; J F Holland
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

3.  Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.

Authors:  C C Bailey; C G Geary; M C Israëls; J A Whittaker; M J Brown; D J Weatherall
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions.

Authors:  R G Graw; C D Buckner; J Whang-Peng; B G Leventhal; G Krüger; C Berard; E S Henderson
Journal:  Lancet       Date:  1970-08-15       Impact factor: 79.321

5.  Evaluation of 216 four-year survivors of acute leukemia.

Authors:  C Jacquillat; M Weil; M F Gemon; V Izrael; G Schaison; G Auclerc; A R Ablin; G Flandrin; J Tanzer; A Bussel; C Weisgerber; C Dresch; Y Najean; M Goudemand; M Seligmann; M Boiron; J Bernard
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

6.  Platelet transfusions from HL-A compatible unrelated donors to alloimmunized patients.

Authors:  H P Lohrmann; M I Bull; J A Decter; R A Yankee; R G Graw
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

7.  Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults.

Authors:  R R Ellison; J F Holland; M Weil; C Jacquillat; M Boiron; J Bernard; A Sawitsky; F Rosner; B Gussoff; R T Silver; A Karanas; J Cuttner; C L Spurr; D M Hayes; J Blom; L A Leone; F Haurani; R Kyle; J L Hutchison; R J Forcier; J H Moon
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

8.  Comparison of methotrexate with 6-mercaptopurine-prednisone in treatment of acute leukemia in adults.

Authors:  W R Vogler; C M Huguley; R W Rundles
Journal:  Cancer       Date:  1967-08       Impact factor: 6.860

9.  Factors in pathogenesis of central-nervous-system leukaemia.

Authors:  R J West; J Graham-Pole; R M Hardisty; M C Pike
Journal:  Br Med J       Date:  1972-08-05

10.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.